Since the drug policy of 1986, many changes have been introduced liberalising the environment for drug manufacturing and marketing. These changes have apparently come about as a response to the drug industry's plea that controls in India were too stringent and that without controls prices would stabilise and not rise. Yet, a categorywise analysis of prices of drugs over a period of 15 years shows that there is a general rising trend in prices, especially of essential and life-saving drugs.